Home
Baker Bros. Advisors reported a 4.99% stake in Candel Therapeutics CADL · 2,455,108 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 4.99%
- Last report
- 6.8% · filed 25/02/14
- Shares held
- 2,455,108 sh
- Class
- Common Stock, par value $0.01 per share
- Holder
- Baker Bros. Advisors
- Event date
- 25/03/31
- Filed
- 25/05/15
4.99% stake · below 5%
- Stake
- 4.99%
- Last report
- 6.8%
- Since last report
- −1.8pp
Candel Therapeutics trades, last 26 weeks
What else happened in Candel Therapeutics around then
Filed or reported within 30 days of the trade day · 25/03/01~25/04/30Baker Bros. Advisors's other 5% stake reports
- Baker Bros. Advisors
5% stakeKodiak Sciences
5% stakeKodiak Sciences
KOD
35% stake
22,049,297 sh
35% stake
Filed 09/30
- Baker Bros. Advisors
5% stakeBeOne Medicines
5% stakeBeOne Medicines
ONC
7.8% stake
115,912,814 sh
7.8% stake
Filed 09/16
- Baker Bros. Advisors
5% stakeIdeaya Biosciences
5% stakeIdeaya Biosciences
IDYA
5.2% stake
5,010,030 sh
5.2% stake
Filed 08/14
- Baker Bros. Advisors
5% stakeRevolution Medicines
5% stakeRevolution Medicines
RVMD
5.3% stake
11,443,357 sh
5.3% stake
Filed 08/14
- Baker Bros. Advisors
5% stakeImmatics
5% stakeImmatics
IMTX
7% stake
9,508,565 sh
7% stake
Filed 08/14
